The American Society of Clinical Oncology (ASCO) opened its clinical guideline draft, ctDNA Testing in Solid Tumors and Lymphoma for public comment. The five recommendations were developed following a literature search that examined research published between January 2017 and March 2023.
Click here to view the draft (after agreeing to ASCO’s confidentiality agreement) and to submit any feedback.
The public comment window is open through August 4, 2025.
Sign up for alerts to keep up with the latest clinical guidelines and draft updates.
Copyright © 2025 Guideline Central, all rights reserved.